Dr Reddy's Laboratories Ltd DRREDDY-IN:National Stock Exchange of India

*Data is delayed | Exchange | INR
Last | 04/30/24 IST
6,204.30quote price arrow down-92.80 (-1.47%)
Volume
381,304
52 week range
4,384.05 - 6,505.90
Loading...
  • Open6,299.90
  • Day High6,313.00
  • Day Low6,185.00
  • Prev Close6,297.10
  • 52 Week High6,505.90
  • 52 Week High Date02/28/24
  • 52 Week Low4,384.05
  • 52 Week Low Date05/19/23

Key Stats

  • Market Cap12,493.83M
  • Shares Out166.53M
  • 10 Day Average Volume426,597.7
  • Dividend40.00
  • Dividend Yield0.64%
  • Beta-
  • YTD % Change6.69

KEY STATS

  • Open6,299.90
  • Day High6,313.00
  • Day Low6,185.00
  • Prev Close6,297.10
  • 52 Week High6,505.90
  • 52 Week High Date02/28/24
  • 52 Week Low4,384.05
  • 52 Week Low Date05/19/23
  • Market Cap12,493.83M
  • Shares Out166.53M
  • 10 Day Average Volume426,597.7
  • Dividend40.00
  • Dividend Yield0.64%
  • Beta-
  • YTD % Change6.69

RATIOS/PROFITABILITY

  • EPS (TTM)314.38
  • P/E (TTM)19.74
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date07/11/2023
  • Div Amount40.00
  • Split Date-
  • Split Factor-

Latest On Dr Reddy's Laboratories Ltd

 

Profile

MORE
Dr. Reddy’s Laboratories Limited is an India-based global pharmaceutical company. The Company offers a portfolio of products and services, including active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC). Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. The Company’s segments include Pharmaceutical Services and Active Ingredients, Global...
Kallam Reddy
Chairman of the Board
Erez Israeli
Chief Executive Officer
Parag Agarwal
Chief Financial Officer
Phanimitra B.
Chief Information Officer
Address
8-2-337, Road No.3 Banjara Hills
Hyderabad
500034
India